(INNS)
KANRIVITUG(INNC)
IMMUNOGLOBULIN G1-LAMBDA, ANTI-[HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-451) [VH (HOMO SAPIENS IGHV4-59*11 (97.9%) -(IGHD) - IGHJ5*02 (93.8%), CDR-IMGT [8.7.15] (26-33.51- 57.96-110)) (1-121) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS (450-451)) (122- 451)], (224-217')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-218') [V- LAMBDA (HOMO SAPIENS IGLV1-40*01 (94.9%) -IGLJ1*01 (100%), CDR-IMGT [9.3.12] (26-34.52-54.91-102)) (1'-112') -HOMO SAPIENS IGLC2*01 (100%) (113'-218')]; DIMER (230-230'':233- 233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
CANRIVITUGUM(INN)